Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about P2RY12 INHIBITION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| FOAM CELL FORMATION | inhibits | entity | 0.95 |
| Advanced Atherosclerosis | associated_with | disease | 0.90 |
| Atherosclerosis | suppresses | disease | 0.90 |
| CHOLESTEROL EFFLUX | activates | entity | 0.90 |
| Lipid Accumulation | associated_with | phenotype | 0.90 |
| atherosclerosis | treats | disease | 0.85 |
| Autophagy | activates | process | 0.85 |
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Pharmacological P2RY12 inhibition (ticagrelor/clopidogrel) a | 0.583 | neurodegeneration | How does P2RY12-mediated VSMC dysfunctio |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning P2RY12 INHIBITION in their description or question text
No additional research found